https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-30 / Biomedicines 2019 Aug;7(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-30 / Biomedicines 2019 Aug;7(3)2019-08-30 00:00:002021-11-15 13:22:59Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-27 / Front Oncol 2019;9:811
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-27 / Front Oncol 2019;9:8112019-08-27 00:00:002019-08-27 00:00:00Low Photosensitizer Dose and Early Radiotherapy Enhance Antitumor Immune Response of Photodynamic Therapy-Based Dendritic Cell Vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-14 / Front Immunol 2019;10:1939
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-14 / Front Immunol 2019;10:19392019-08-14 00:00:002023-03-07 12:33:09Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-09 / J Extracell Vesicles 2019;8(1):1648995
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-09 / J Extracell Vesicles 2019;8(1):16489952019-08-09 00:00:002020-08-31 08:17:52Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-08 / Front Immunol 2019;10:1832
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-08 / Front Immunol 2019;10:18322019-08-08 00:00:002019-08-08 00:00:00A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-07 / World J Gastroenterol 2019 Aug;25(29):3941-3955
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-07 / World J Gastroenterol 2019 Aug;25(29):3941-39552019-08-07 00:00:002019-08-07 00:00:00Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-07-21 / World J. Gastroenterol. 2019 Jul;25(27):3649-3663
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-07-21 / World J. Gastroenterol. 2019 Jul;25(27):3649-36632019-07-21 00:00:002019-07-21 00:00:00Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-07-18 / Oncoimmunology 2019;8(11):e1638212
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-07-18 / Oncoimmunology 2019;8(11):e16382122019-07-18 00:00:002019-07-18 00:00:00Trial watch: dendritic cell vaccination for cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-07-07 / World J. Gastroenterol. 2019 Jul;25(25):3151-3167
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-07-07 / World J. Gastroenterol. 2019 Jul;25(25):3151-31672019-07-07 00:00:002019-07-07 00:00:00Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-06-28 / World J. Gastroenterol. 2019 Jun;25(24):2977-2989
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-06-28 / World J. Gastroenterol. 2019 Jun;25(24):2977-29892019-06-28 00:00:002019-06-28 00:00:00Immunotherapy for hepatocellular carcinoma: Current and future
